Department of Nephrology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Department of Obstetrics and Gynecology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Clin Transplant. 2021 Aug;35(8):e14349. doi: 10.1111/ctr.14349. Epub 2021 May 25.
Kidney transplantation (KT) is the best option for many women with end-stage renal disease desiring pregnancy. The aim of this study was to investigate obstetric and graft outcomes among KT recipient women in our center.
Maternal and fetal data were assessed in 29 pregnancies of 18 female KT recipients. Each patient was matched with two controls without pregnancy history for factors known to affect graft function. According to pre-pregnancy levels, serum creatinine and eGFR slope in the gestational and postpartum periods were calculated as percentages.
The main maternal and fetal complications were preeclampsia (38%) and preterm births (38%), respectively. Pregnancy (odds ratio [OR]: 5.09; p = .02), proteinuria in the third trimester (OR: 5.52; p = .02), proteinuria in postpartum third months (OR: 7.4; p = .008) and stable creatinine levels in the first 6 months of pregnancy (OR: 11.25 p = .03) were associated with graft dysfunction. Postpartum first year eGFR decline (-16.8% vs. -6.7%; p = .04) and second-year eGFR decline (-18.5% vs. -8.3%; p = .04) were significantly higher in the pregnancy group than those matched controls.
Pregnancy after KT is associated with high rates of maternal and fetal complications. The sustained decline of eGFR may suggest an increased risk of graft loss compared to recipients with similar clinical characteristics.
对于许多患有终末期肾病并希望怀孕的女性来说,肾移植(KT)是最佳选择。本研究旨在调查我们中心 KT 受者女性的产科和移植物结局。
评估了 18 名女性 KT 受者的 29 例妊娠的母婴数据。每位患者均与两名无妊娠史的对照者进行了匹配,以评估已知影响移植物功能的因素。根据妊娠前水平,计算了妊娠和产后期间血清肌酐和 eGFR 斜率的百分比。
主要的母婴并发症分别为子痫前期(38%)和早产(38%)。妊娠(优势比 [OR]:5.09;p=0.02)、孕晚期蛋白尿(OR:5.52;p=0.02)、产后第三个月蛋白尿(OR:7.4;p=0.008)和妊娠前 6 个月稳定的肌酐水平(OR:11.25;p=0.03)与移植物功能障碍相关。与匹配对照组相比,产后第一年 eGFR 下降(-16.8%比-6.7%;p=0.04)和第二年 eGFR 下降(-18.5%比-8.3%;p=0.04)在妊娠组中明显更高。
KT 后妊娠与母婴并发症发生率高有关。与具有相似临床特征的受者相比,eGFR 的持续下降可能表明移植物丢失的风险增加。